If mucinous appendiceal tumours widely distributed throughout the peritoneal space are completely removed by peritonectomy procedures, quality of life and survival benefits result with an acceptable morbidity and mortality. In some patients mucinous tumour that surrounds the stomach is an important consideration in accomplishing a complete cytoreduction. Methods: Mucinous tumour that enters the lesser sac through the foramen of Winslow will accumulate by gravity in the subpyloric space. This is a cul-de-sac beneath the pylorus. For complete cytoreduction mucinous tumour accumulation in the subpyloric space must be cleared. Results: If there is tumour accumulation in the subpyloric space and the left gastric artery can be preserved by peritonectomy, one can achieve a complete cytoreduction without gastrectomy. In a majority of patients, resection of mucinous tumour from the subpyloric space requires total gastrectomy for complete cytoreduction. Conclusion: Knowledge of mucinous tumour distribution and anatomy of the subpyloric space will facilitate complete cytoreduction in selected patients with pseudomyxoma peritonei syndrome. 
INTRODUCTION
heterogeneous tumour types include rapidly fatal diseases Gastrointestinal cancer that perforates the bowel wall as well as indolent tumours that slowly progress over will seed itself in a random fashion on peritoneal surfaces several years, even decades. Nevertheless, even though nearby the site of perforation. In contrast, mucinous the disease may have a long natural history and rarely tumours, especially those that are minimally invasive, do disseminates to lymph nodes or to the liver, in not immediately adhere, implant, and progress. Mucinous the absence of special treatments all patients die of cancer cells within the peritoneal space migrate so pseudomyxoma peritonei. 3 In order to more precisely that their pattern of growth has been described as define this disease regarding treatment options and redistribution. 1 Mucinous tumours from many different prognosis with cytoreductive surgery, Sugarbaker et al. sources may have this characteristic peritoneal surface defined the pseudomyxoma peritonei syndrome. 4 In this distribution. The most frequent example is the syndrome the mucinous tumour had a characteristic pseudomyxoma peritonei syndrome that results from distribution within the abdomen and pelvis and the the perforation of an appendiceal adenoma.
primary tumour was a perforated appendiceal adenoma. The natural history of pseudomyxoma peritonei has Ronnett et al. showed that the primary tumour in women caused much confusion. The term was first used by was a perforated appendiceal adenoma even though the Werth in 1884 to describe a massive intraperitoneal ovarian involvement was massive.
5 accumulation of mucinous tumour; he associated the With these mucinous tumours three different physical condition with an ovarian mucinous tumour of low parameters control the distribution of tumour. 6 First, biological aggressiveness. 2 Unfortunately mucinous resorption of peritoneal fluid will cause tumour cells to tumour widely distributed throughout the abdomen accumulate at a particular site. This is true of the lymphoid and pelvis from numerous different primary sites has accumulations within the greater omentum, lesser omentum, and the junction of small bowel and small bowel mesentery. A mucinous tumour accumulation tumour cells at dependent sites within the abdomen and random fashion as they migrate within the peritoneal cavity. Gravity would cause local accumulations of these pelvis. Mucinous tumour masses in the pelvis and right retrohepatic space are examples of gravity-dependent mucinous tumour cells within the lesser sac. The first portion of the duodenum creates an anatomic barrier distribution. Other examples of gravity-dependent tumour accumulations are the dependent area created that results in a cul-de-sac just inside the foramen of Winslow. By gravity single tumour cells would by the left colon and left paracolic sulcus, the cul-de-sac created by the ligament of Treitz, and the ileocecal valve preferentially accumulate within this space and as they progress result in a large mass at this site. Our hypothesis region. Our observations suggest that the subpyloric space accumulates mucinous tumour by this mechanism.
is that tumour accumulation within the subpyloric space occurs by gravity effect on tumour cells entering through The third mechanism controlling mucinous tumour accumulation is fibrin entrapment. In this situation, prior the foramen of Winslow (Fig. 2 ). surgery and the abraded (sticky) peritoneal surfaces that result will cause cancer cells to accumulate within the Cytoreduction of mucinous tumour from fibrin clot at the injured site.
The purpose of this manuscript is to describe the the subpyloric space mucinous tumour accumulations that are repeatedly In performing cytoreductive surgery five peritonectomy observed within the omental bursa posterior to procedures are performed using a centripetal approach: the pylorus, and to suggest a mechanism whereby greater omentectomy-splenectomy, left subphrenic tumour accumulates at this site, and to document peritonectomy, right subphrenic peritonectomy, lesser the peritonectomy that is required to complete a omentectomy-cholecystectomy, and complete pelvic cytoreduction with tumour in this anatomic site.
peritonectomy. 7 If these dissections can be completed then surgical strategies for clearing the mucinous tumour from surrounding the stomach and first portion of the METHODS duodenum should be considered. If the vascularity of the stomach can be preserved by sparing the left gastric
Anatomic description
artery and vein, then a subpyloric peritonectomy should In performing cytoreductive surgery on 550 patients with be performed. If there is compromise of these vessels pseudomyxoma peritonei syndrome an accumulation of by a large volume of tumour densely adherent to the tumour beneath the pylorus is significant surgically in distal stomach, then total gastrectomy is necessary. approximately 15% of patients. This may progress to
To resect the subpyloric tumour accumulation the cause obstruction of the outlet of the stomach. The first portion of the duodenum is dissected free by ligating abdominal CT in Figure 1 shows the characteristic and dividing the branches of the right gastroepiploic and appearance of the tumour accumulation posterior to the right gastric vessels. By blunt dissection the first portion stomach. Its borders are the pylorus and antrum of the of the duodenum is then freed of mucinous tumour. A stomach anteriorly, the duodenum to the right, and the linear cutting stapler is used to divide the duodenum head of the pancreas posteriorly. just distal to the pylorus. With traction on the stomach specimen the peritoneum with adherent mucinous tumour is dissected away from the head of the pancreas. Similarly, tumour and peritoneum are electroevaporated
Mechanism of tumour accumulation
from the caudate process and left side of the inferior An important issue in the pathobiology of mucinous vena cava. 8 The floor of the omental bursa is bluntly peritoneal carcinomatosis concerns the mechanism stripped toward the left gastric vessels. After dividing whereby a large volume of disease accumulates posterior the phreno-esophageal ligament the gastroesophageal to the antrum of the stomach. The mechanisms whereby junction is divided using a linear cutting stapler. As a final the distribution of mucinous tumour occurs at other step in the gastrectomy the left gastric vessels are ligated sites within the abdomen and pelvis should also explain and suture ligated. the large deposits posterior to the pylorus.
In repeatedly clearing mucinous tumour from this site it was established that the tumour was within the lesser
Reconstruction following total
sac and could not be approached from the peritoneal gastrectomy with extensive cytoreduction cavity. The retropyloric tumour mass was confluent with that occurring on the floor of the omental bursa. The two
The reconstruction following total gastrectomy in a patient with extensive cytoreductive surgery is staged. most prominent mechanisms controlling large tumour accumulations are gravity and peritoneal fluid resorption.
Following the gastrectomy the patient receives intraperitoneal chemotherapy using mitomycin C at There is no known site for peritoneal fluid resorption within the omental bursa. However, mucinous tumour 41°C and continuous manual manipulation. 9 Then the oesophago-jejunostomy and other anastomoses to cells would be expected to enter the lesser sac in a Figure 1 The subpyloric space is seen on the CT scan of a patient with widespread mucinous tumour from a perforated appendiceal malignancy. The histology showed a hybrid type of tumour with areas of both adenomucinosis and mucinous adenocarcinoma present. Its removal required total gastrectomy. Both the left gastric artery and vein were intimately involved by the tumour mass. establish intestinal continuity are performed. The
The mucinous tumour in the subpyloric space has entero-enterostomy, in order to complete the Rouxoften been thought to represent perigastric lymph-node en-Y reconstruction, is not performed. A temporary metastases. If it were lymph nodal dissemination then diverting jejunostomy is performed.
10 Post-operatively the gastrectomy would not be indicated. In our database the patient receives early post-operative intraperitoneal of 655 patients only three patients have had lymph nodal 5-fluorouracil. At approximately 6 months this diversion metastases from the tumour that surrounds the stomach is closed. At the time of ostomy closure a secondand the left gastric vessels. In this situation the prognosis look procedure and an additional cycle of peri-operative has been extremely guarded. These patients have gone chemotherapy is used. Short-term results of treatment on to recur despite complete cytoreduction. However, of 50 patients have been excellent and morbidity and in those patients where peritoneal surface malignancy is mortality acceptable; long-term evaluation of total contained within the subpyloric space the celiac lymph gastrectomy for pseudomyxoma peritonei syndrome is nodes are not dissected except to facilitate the total pending. 10 gastrectomy dissection.
In the past extensive perigastric tumour was consistently associated with an incomplete cyto-DISCUSSION reduction. In these patients serial debulking was associated with a median survival of approximately 3 The subpyloric space is the most dependent portion of years and a 5% 5-year survival. 3 Options to complete the omental bursa in an erect patient. Its position within cytoreduction with intraperitoneal chemotherapy the lesser sac is similar to the cul-de-sac (Douglas pouch) may be debulking surgery combined with systemic within the larger abdominopelvic space. Accumulation of chemotherapy. 11 In the past total gastrectomy had not tumour in a dependent fashion directed by gravity causes been utilized as a visceral peritonectomy procedure. We the relatively large volume of tumour to develop at the lowest point within the lesser sac.
now consider this the fifth standardized peritonectomy this group of patients is pancreatitis. The investing fascia of the pancreas is removed completely. Sometimes, the mucinous tumour will invade the anterior aspect of the pancreas. The dissection that is utilized must be electroevaporative surgery or the positive margins will recur. 7 A minimum of two closed-suction drains at the lower aspect of the pancreas and in the left upper quadrant are indicated in order to remove any enzymerich material that may leak from the surface of the pancreas.
This cytoreduction, if complete, must be combined with perioperative intraperitoneal chemotherapy if there is to be a long-term disease-free survival. We have used heated intraoperative intraperitoneal mitomycin C. 9 In addition, early post-operative intraperitoneal 5-fluorouracil is used in a majority of these patients. One exception is the very minimally aggressive adenomucinosis type of pseudomyxoma peritonei. In these patients the early post-operative intraperitoneal 5-fluorouracil is usually withheld. The heated intraoperative mitomycin C is given in all other patients. 
